AstraZeneca shares rise as UK coronavirus vaccine trial resumes
(Reuters) – Shares of AstraZeneca <AZN.L> rose 1% to 8,516 pence on Monday after the British drugmaker received the go-ahead from safety watchdogs over the weekend to resume clinical trials for its COVID-19 vaccine candidate in the United Kingdom. The resumption of the trials for the vaccine, one of the most advanced in development and … Read more